RELX plc stock (GB00B2B0DG97): Drops 1.5% to $32.77 amid valuation debate

RELX plc shares fell 1.50% to $32.77 on May 12, 2026, extending a six-day losing streak. A fresh DCF analysis on May 13 flags the stock as overvalued at intrinsic values of $20-$23 versus current price, per GuruFocus.

RELX plc stock declined 1.50% on Tuesday, May 12, 2026, closing at $32.77 after dropping from $33.27, according to StockInvest.us as of May 13, 2026. The decline marks the sixth consecutive day of losses for the London-listed information and analytics provider. Separately, a DCF valuation published May 13, 2026, estimates RELX's intrinsic value at $20.23 based on earnings and $23.10 on free cash flow, suggesting overvaluation with a -62% margin of safety, per GuruFocus as of May 13, 2026.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: RELX plc
• Sector/industry: Information services and analytics
• Headquarters/country: United Kingdom
• Core markets: North America, Europe
• Key revenue drivers: Risk solutions, scientific publishing
• Home exchange/listing venue: London Stock Exchange (REL), NYSE (RELX)
• Trading currency: USD (NYSE), GBP (LSE)

RELX plc: core business model

RELX plc operates as a global provider of information-based analytics and decision tools, serving professional and institutional customers in over 180 countries. The company focuses on three main areas: Risk (40% of 2024 revenue), Scientific, Technical & Medical (STM, 29%), and Legal (27%), with Exhibitions making up the rest, based on the full-year 2024 report published March 2025 via RELX investor relations as of March 2025. Its business model emphasizes recurring subscription revenue, which accounted for 73% of total sales in 2024.

Risk solutions, including LexisNexis Risk Solutions, leverage proprietary data and AI to combat fraud and support credit decisions, generating high-margin growth. STM powers research workflows through platforms like ScienceDirect, while Legal provides workflow software for law firms and corporations. This segment mix offers resilience for US investors via NYSE listing (ticker: RELX), exposing portfolios to global data analytics trends amid rising AI adoption.

Main revenue and product drivers for RELX plc

Risk remains the largest driver, with 7% underlying revenue growth in 2024 driven by AI-enabled fraud prevention and insurance analytics, per the annual report published March 2025. Key products include WorldCheck for compliance screening and AutoTrack for identity verification, bolstered by proprietary datasets covering billions of records. North America contributes over 50% of Risk revenue, linking RELX to US financial services demand.

Legal revenue grew 8% in 2024, fueled by Lexis+ AI, a generative AI legal research tool launched in 2023 and expanded in 2025. STM saw 5% growth from content subscriptions and analytics tools. Exhibitions rebounded post-pandemic but remain cyclical. Overall, RELX reported 7% underlying revenue growth and 9% adjusted operating profit growth for 2025 in recent updates, underscoring subscription stability for US investors tracking tech-enabled services.

Industry trends and competitive position

The information services sector benefits from digitization and AI integration, with data analytics markets projected to grow at 12% CAGR through 2030 per Statista data published 2025. RELX holds a strong moat via proprietary data assets and scale, competing with Thomson Reuters in legal and Elsevier's STM dominance. Recent AI pushes, like partnerships in legal tech, position it against disruptors, though debates on AI moats persist as noted in May 2026 commentary.

Why RELX plc matters for US investors

RELX's NYSE ADR listing provides US investors direct access to a FTSE 100 constituent with 55% North American revenue exposure. Its Risk business ties into US regulatory demands like AML and data privacy, while Legal and STM serve key US markets in finance, insurance, and academia. Dividend yield around 1.5% (2024 payout) and £2-3bn annual buybacks enhance appeal amid S&P 500 data analytics rotation.

Conclusion

RELX plc faces short-term pressure from a six-day price decline to $32.77 as of May 12, 2026, alongside DCF models indicating overvaluation versus $20-23 intrinsic estimates. Strong fundamentals persist with AI-driven growth in Risk and Legal segments, 7-9% profit expansion in recent periods, and robust subscription revenue. US investors may monitor NYSE-traded shares for data analytics exposure, balancing valuation concerns with operational momentum.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.